Because of the fact that C-peptide is produced in equimolar amounts to endogenous insulin, its elevated levels are characteristic of insulin resistance and the metabolic syndrome phenotype (42), which are associated with hyperinsulinemia (43). This evidence concerns the gene INS and metabolic syndrome.